Hormone replacement therapy [topp]
haemostatic [ortf]
variables [qlco]
Post-Menopause [orgf]
Women [popg]
Objective [inpr]
Hormone replacement therapy [topp]
Promote [acty]
Last [qlco]
Quality [qlco]
Life [idcn]
Risks [qlco]
Osteoporotic Fractures [dsyn]
coronary heart disease [dsyn]
Controlled Clinical Trials, Randomized [resa]
Reported [inpr]
Hormone replacement therapy [topp]
Usage [ftcn]
Increased [qnco]
Myocardial Infarction [dsyn]
Stroke [dsyn]
Venous Thrombosis [patf]
Conduct [inbe]
Study [mnob]
Evaluate [ftcn]
Levels [qlco]
haemostatic [ortf]
Parameters [fndg]
Group [idcn]
Estrogen [horm, phsu, strd]
Age [orga]
Methods [inpr]
Study [mnob]
Health [idcn]
Women [popg]
Observational Study [resa]
divided [ftcn]
3 groups [inpr]
Women [popg]
Post-Menopause [orgf]
Hormone replacement therapy [topp]
months [tmco]
Five [qnco]
Women [popg]
Post-Menopause [orgf]
Hormone replacement therapy [topp]
Five [qnco]
Women [popg]
Young [tmco]
Pre-Menopause [phsf]
Women [popg]
Age [orga]
Range [qnco]
Hormone replacement therapy [topp]
Group [idcn]
Women [popg]
Gynaecologist [prog]
Private [orgt]
clinics [hcro, mnob]
Group [idcn]
RANDOM [resa]
society [orgt]
Syria [geoa]
Estradiol [horm, phsu, strd]
Fibrinogen [aapp, bacs, phsu]
Antithrombin III [aapp, phsu]
Protein C [aapp, bacs, phsu]
Women [popg]
Compared [acty]
Post-Menopause [orgf]
User Group [popg]
Current [tmco]
Hormone replacement therapy [topp]
Users [humn]
Levels [qlco]
Estradiol [horm, phsu, strd]
Levels [qlco]
Antithrombin III [aapp, phsu]
Protein C [aapp, bacs, phsu]
Levels [qlco]
Fibrinogen [aapp, bacs, phsu]
Compared [acty]
Pre-Menopause [phsf]
Group [idcn]
Current [tmco]
Users [humn]
Levels [qlco]
Estradiol [horm, phsu, strd]
Antithrombin III [aapp, phsu]
Protein C [aapp, bacs, phsu]
Levels [qlco]
Fibrinogen [aapp, bacs, phsu]
Post-Menopause [orgf]
Users [humn]
Women [popg]
Levels [qlco]
Fibrinogen [aapp, bacs, phsu]
Levels [qlco]
Antithrombin III [aapp, phsu]
Protein C [aapp, bacs, phsu]
Compared [acty]
Pre-Menopause [phsf]
Women [popg]
Hormone replacement therapy [topp]
treatment [ftcn]
fibrinogen levels [lbpr]
Decrease [qlco]
Antithrombin III [aapp, phsu]
Protein C level [lbpr]
